Sarepta Therapeutics Inc (SRPT)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$21.30
Buy
$21.53
$-0.22 (-1.01%)
Prices updated at 13 Dec 2025, 00:59 EST
| Prices minimum 15 mins delay
Prices in USD
Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 83.22 |
| 2023 | 87.91 |
| 2022 | 85.00 |
| 2021 | 86.17 |
| 2020 | 88.26 |
| 2019 | 85.14 |
| 2018 | 88.64 |
| 2017 | 95.24 |
| 2016 | 98.14 |
| 2015 | 100.00 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 0.99 |
| 2024 | 7.46 |
| 2023 | 7.72 |
| 2022 | 12.88 |
| 2021 | 11.09 |
| 2020 | 26.47 |
| 2019 | 25.49 |
| 2018 | 25.91 |
| 2017 | 30.62 |
| 2016 | 1,012.69 |
| 2015 | 59,144.21 |
Price/Forward earnings (YTD)
17.36
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 6.51 |
| 2023 | -16.77 |
| 2022 | -22.42 |
| 2021 | -13.66 |
| 2020 | -23.05 |
| 2019 | -41.28 |
| 2018 | -24.54 |
| 2017 | -5.85 |
| 2016 | -76.59 |
| 2015 | -77.36 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 2.59 |
| 2023 | 3.80 |
| 2022 | 8.13 |
| 2021 | 3.39 |
| 2020 | 3.92 |
| 2019 | 2.23 |
| 2018 | 1.59 |
| 2017 | 1.66 |
| 2016 | 1.26 |
| 2015 | 1.44 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
